Loading...

We've got a brand new version of Simply Wall St! Try it out

Empower Clinics

CNSX:CBDT
Snowflake Description

Weak fundamentals or lack of information.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CBDT
CNSX
CA$10M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Empower Clinics Inc. owns and operates physician-staffed medical cannabis clinics in the United States. The last earnings update was 32 days ago. More info.


Add to Portfolio Compare Print
CBDT Share Price and Events
7 Day Returns
-6.7%
CNSX:CBDT
1.6%
CA Healthcare
1.2%
CA Market
1 Year Returns
-65%
CNSX:CBDT
-2%
CA Healthcare
-0.2%
CA Market
CBDT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Empower Clinics (CBDT) -6.7% -30% -50% -65% - -
CA Healthcare 1.6% 0.5% -9.4% -2% -15.3% 15.5%
CA Market 1.2% 4.2% 1.5% -0.2% 8.4% 1.8%
1 Year Return vs Industry and Market
  • CBDT underperformed the Healthcare industry which returned -2% over the past year.
  • CBDT underperformed the Market in Canada which returned -0.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Empower Clinics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Empower Clinics. This is due to cash flow or dividend data being unavailable. The share price is CA$0.07.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Empower Clinics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Empower Clinics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:CBDT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.01
CNSX:CBDT Share Price ** CNSX (2019-09-13) in CAD CA$0.07
CNSX:CBDT Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.05
Canada Healthcare Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Companies 55.38x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 14.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Empower Clinics.

CNSX:CBDT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:CBDT Share Price ÷ EPS (both in USD)

= 0.05 ÷ -0.01

-5.17x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Empower Clinics is loss making, we can't compare its value to the CA Healthcare industry average.
  • Empower Clinics is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Empower Clinics's expected growth come at a high price?
Raw Data
CNSX:CBDT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.17x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Healthcare Industry PEG Ratio Median Figure of 48 Publicly-Listed Healthcare Companies 1.76x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.98x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Empower Clinics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Empower Clinics's assets?
Raw Data
CNSX:CBDT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $0.00
CNSX:CBDT Share Price * CNSX (2019-09-13) in CAD CA$0.07
CNSX:CBDT Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.05
Canada Healthcare Industry PB Ratio Median Figure of 23 Publicly-Listed Healthcare Companies 2.29x
Canada Market PB Ratio Median Figure of 2,452 Publicly-Listed Companies 1.44x
CNSX:CBDT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:CBDT Share Price ÷ Book Value per Share (both in USD)

= 0.05 ÷ 0.00

19.72x

* Primary Listing of Empower Clinics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Empower Clinics is overvalued based on assets compared to the CA Healthcare industry average.
X
Value checks
We assess Empower Clinics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Empower Clinics has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Empower Clinics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Empower Clinics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
37.9%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Empower Clinics expected to grow at an attractive rate?
  • Unable to compare Empower Clinics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Empower Clinics's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Empower Clinics's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:CBDT Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 37.9%
Canada Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 17.9%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:CBDT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:CBDT Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 1 -2 -1
2019-03-31 1 -3 -2
2018-12-31 1 -3 -4
2018-09-30 1 -3 -7
2018-06-30 1 -3 -6
2018-03-31 1 -1 -3
2017-12-31 2 -2 -3
2017-09-30 1 -2 -3
2016-12-31 2 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Empower Clinics is high growth as no earnings estimate data is available.
  • Unable to determine if Empower Clinics is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:CBDT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Empower Clinics Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBDT Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.01
2019-03-31 -0.03
2018-12-31 -0.06
2018-09-30 -0.11
2018-06-30 -0.11
2018-03-31 -0.07
2017-12-31 -0.06
2017-09-30 -0.07
2016-12-31 -0.14

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Empower Clinics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Empower Clinics's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. Empower Clinics's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Empower Clinics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Empower Clinics has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Empower Clinics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Empower Clinics's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Empower Clinics does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Empower Clinics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Empower Clinics's 1-year growth to the North America Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Empower Clinics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Empower Clinics Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBDT Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 1.22 -0.89 3.39
2019-03-31 0.94 -1.91 2.98
2018-12-31 1.09 -3.79 4.86
2018-09-30 1.19 -6.72 5.61
2018-06-30 1.30 -5.93 4.79
2018-03-31 1.40 -3.17 3.05
2017-12-31 1.51 -3.11 3.17
2017-09-30 1.49 -2.77 2.88
2016-12-31 2.13 -1.59 2.53

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Empower Clinics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Empower Clinics has efficiently used its assets last year compared to the CA Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Empower Clinics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Empower Clinics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Empower Clinics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Empower Clinics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Empower Clinics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Empower Clinics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Empower Clinics's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Empower Clinics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Empower Clinics Company Filings, last reported 2 months ago.

CNSX:CBDT Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 0.36 2.38 0.82
2019-03-31 -3.05 1.85 1.97
2018-12-31 -3.00 1.77 0.16
2018-09-30 -2.83 1.68 0.28
2018-06-30 -2.64 1.29
2018-03-31 -4.67 3.36 0.75
2017-12-31 -4.81 2.94
2017-09-30 -3.99 2.46 0.00
2016-12-31 -1.88 1.19 0.01
  • Empower Clinics's level of debt (664.1%) compared to net worth is high (greater than 40%).
  • Unable to establish if Empower Clinics's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Empower Clinics has less than a year of cash runway based on current free cash flow.
  • Empower Clinics has less than a year of cash runway if free cash flow continues to grow at historical rates of 41.1% each year.
X
Financial health checks
We assess Empower Clinics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Empower Clinics has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Empower Clinics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Empower Clinics dividends.
If you bought CA$2,000 of Empower Clinics shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Empower Clinics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Empower Clinics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:CBDT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 25 Stocks 1.6%
Canada Market Average Dividend Yield Market Cap Weighted Average of 333 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Empower Clinics has not reported any payouts.
  • Unable to verify if Empower Clinics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Empower Clinics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Empower Clinics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Empower Clinics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Empower Clinics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Empower Clinics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Empower Clinics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Steve McAuley
TENURE AS CEO 0.7 years
CEO Bio

Mr. Steven J. McAuley, also known as Steve, founded ControlBox.com LLC and serves as its Chief Executive Officer. Mr. McAuley served as Chief Executive Officer of XPEL Technologies Corp., from January 2007 to June 10, 2008. Mr. McAuley is a successful business leader and Corporate Director with 20 years’ experience in the automotive, financial services and technology industries. He served as Chief Executive Officer for GE Capital in Europe. He served as Senior Vice President of Financial Services for Penske Automotive Group NYSE. He has a breadth of technical knowledge and corporate know how to building a great company based upon solving real consumer and business communication technology problems on the Internet. Mr. McAuley has a tremendous level of experience. While working at UnitedAuto, he was responsible for reviewing, developing strategy and managing U.S. financial services business. He was also involved with new product development, strategy, marketing, forecasting and reporting for the SIRIUS satellite radio offering in UnitedAuto-affiliated car dealerships. He served as Director of XPEL Technologies Corp. from January 15, 2007 to June 10, 2008. He is the President, Chief Executive Officer and Chairman of the Board at Empower Clinics Inc. since January 4, 2019.

CEO Compensation
  • Insufficient data for Steve to compare compensation growth.
  • Insufficient data for Steve to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the Empower Clinics management team in years:

0.5
Average Tenure
  • The average tenure for the Empower Clinics management team is less than 2 years, this suggests a new team.
Management Team

Steve McAuley

TITLE
President
TENURE
0.7 yrs

Mathew Lee

TITLE
CFO & Secretary
TENURE
0.5 yrs

Andrea Klein

TITLE
Vice President of Operations
TENURE
0.4 yrs

Joseph Cohen

TITLE
Chief Technology Officer

Dustin Klein

TITLE
Senior VP of Business Development & Director
TENURE
0.4 yrs
Board of Directors Tenure

Average tenure of the Empower Clinics board of directors in years:

0.4
Average Tenure
  • The average tenure for the Empower Clinics board of directors is less than 3 years, this suggests a new board.
Board of Directors

Steve McAuley

TITLE
President
TENURE
0.7 yrs

Dustin Klein

TITLE
Senior VP of Business Development & Director
TENURE
0.4 yrs

Andy Bunkse

TITLE
Director
AGE
49
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess Empower Clinics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Empower Clinics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Kind Of Shareholders Own Empower Clinics Inc. (CNSX:CBDT)?

CNSX:CBDT Income Statement, September 4th 2019 Hedge funds don't have many shares in Empower Clinics. … Insider Ownership Of Empower Clinics The definition of company insiders can be subjective, and does vary between jurisdictions. … General Public Ownership The general public, who are mostly retail investors, collectively hold 64% of Empower Clinics shares.

Simply Wall St -

Company Info

Description

Empower Clinics Inc. owns and operates physician-staffed medical cannabis clinics in the United States. The company enables individuals to improve and protect their health. It also develops and sells Sollievo cannabidiol products, such as lotion, balms, tinctures, gel caps, pain patches, and an e-drink. The company was incorporated in 2015 and is headquartered in Portland, Oregon.

Details
Name: Empower Clinics Inc.
CBDT
Exchange: CNSX
Founded: 2015
CA$9,560,798
136,582,832
Website: http://www.empowerclinics.com
Address: Empower Clinics Inc.
105 SE 18th Avenue,
Portland,
Oregon, United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX CBDT Common Shares Canadian National Stock Exchange CA CAD 30. Apr 2018
OTCPK EPWC.F Common Shares Pink Sheets LLC US USD 30. Apr 2018
DB 8EC Common Shares Deutsche Boerse AG DE EUR 30. Apr 2018
Number of employees
Current staff
Staff numbers
0
Empower Clinics employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/15 01:35
End of day share price update: 2019/09/13 00:00
Last earnings filing: 2019/08/14
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.